Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndrome
Interventions
DRUG:
DA-6034 3%
DRUG:
DA-6034 5%
DRUG:
DA-6034 Placebo
Sponsor
Dong-A ST Co., Ltd.